Skip to main content

Lineage Cell Therapeutics, Inc.

LCTX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000876343

No open-market purchases or sales by Lineage Cell Therapeutics, Inc. insiders were filed in the last 90 days; 131 institutions reported holding it in 13F filings for Q2 2026, worth $152.7M in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in Lineage Cell Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
100
−8 vs. Q1 2022
Shares held
65.0M
−7.85M (−10.8%) vs. Q1 2022
Total value
$102.7M
−$9.63M (−8.6%) vs. Q1 2022
New holders
20
18 more added
Sold out
28
24 more reduced

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 100 institutions
Q1 2021: 102 institutionsQ2 2021: 115 institutionsQ3 2021: 115 institutionsQ4 2021: 124 institutionsQ1 2022: 109 institutionsQ2 2022: 100 institutionsQ3 2022: 104 institutionsQ4 2022: 106 institutionsQ1 2023: 116 institutionsQ2 2023: 107 institutionsQ3 2023: 104 institutionsQ4 2023: 115 institutionsQ1 2024: 116 institutionsQ2 2024: 113 institutionsQ3 2024: 114 institutionsQ4 2024: 126 institutionsQ1 2025: 127 institutionsQ2 2025: 129 institutionsQ3 2025: 112 institutionsQ4 2025: 123 institutionsQ1 2026: 130 institutionsQ2 2026: 131 institutions
Value heldQ2 2022: $102.7M
Q1 2021: $141.8MQ2 2021: $208.5MQ3 2021: $191.7MQ4 2021: $182.0MQ1 2022: $112.3MQ2 2022: $102.7MQ3 2022: $73.1MQ4 2022: $76.2MQ1 2023: $104.7MQ2 2023: $106.6MQ3 2023: $89.1MQ4 2023: $82.5MQ1 2024: $138.3MQ2 2024: $94.2MQ3 2024: $85.6MQ4 2024: $53.8MQ1 2025: $49.7MQ2 2025: $88.4MQ3 2025: $148.6MQ4 2025: $169.8MQ1 2026: $176.5MQ2 2026: $152.7M
Institutions holding LCTX and their total value by quarter
QuarterHoldersValue
Q2 2026131$152.7M
Q1 2026130$176.5M
Q4 2025123$169.8M
Q3 2025112$148.6M
Q2 2025129$88.4M
Q1 2025127$49.7M
Q4 2024126$53.8M
Q3 2024114$85.6M
Q2 2024113$94.2M
Q1 2024116$138.3M
Q4 2023115$82.5M
Q3 2023104$89.1M
Q2 2023107$106.6M
Q1 2023116$104.7M
Q4 2022106$76.2M
Q3 2022104$73.1M
Q2 2022100$102.7M
Q1 2022109$112.3M
Q4 2021124$182.0M
Q3 2021115$191.7M
Q2 2021115$208.5M
Q1 2021102$141.8M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Lineage Cell Therapeutics, Inc.; share changes are against Q1 2022.

Institutions holding LCTX in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Nuveen Asset Management, LLC0$00.00%−551,993−100.0%Sold out
DekaBank Deutsche Girozentrale0$00.00%−402,100−100.0%Sold out
STRS Ohio0$00.00%−282,700−100.0%Sold out
Allspring Global Investments Holdings, LLC0$00.00%−170,379−100.0%Sold out
Rhumbline Advisers0$00.00%−101,742−100.0%Sold out
Aristides Capital LLC0$00.00%−100,000−100.0%Sold out
Deutsche Bank AG0$00.00%−68,085−100.0%Sold out
American International Group, Inc.0$00.00%−62,265−100.0%Sold out
Manufacturers Life Insurance Company, The0$00.00%−59,658−100.0%Sold out
California State Teachers Retirement System0$00.00%−53,656−100.0%Sold out
DCF Advisers, LLC0$00.00%−53,000−100.0%Sold out
Voya Investment Management LLC0$00.00%−47,315−100.0%Sold out
Invesco Ltd.0$00.00%−34,518−100.0%Sold out
Alliancebernstein L.P.0$00.00%−27,500−100.0%Sold out
ProShare Advisors LLC0$00.00%−23,513−100.0%Sold out
Barclays PLC0$00.00%−20,360−100.0%Sold out
Mirabella Financial Services LLP0$00.00%−18,800−100.0%Sold out
Wealth Architects, LLC0$00.00%−16,100−100.0%Sold out
Amalgamated Bank0$00.00%−15,165−100.0%Sold out
SG Americas Securities, LLC0$00.00%−12,935−100.0%Sold out
USAdvisors Wealth Management, LLC0$00.00%−10,869−100.0%Sold out
Prudential Financial Inc0$00.00%−10,485−100.0%Sold out
Legal & General Group Plc0$00.00%−9,674−100.0%Sold out
LVM Capital Management Ltd0$00.00%−10,000−100.0%Sold out
Ameritas Investment Partners, Inc.0$00.00%−9,508−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−6,964−100.0%Sold out
Simplex Trading, LLC0$00.00%−4,135−100.0%Sold out
O'Dell Group, LLC0$00.00%−2,000−100.0%Sold out
Amalgamated Financial Corp.––––Not filed